ACHE and hepatocellular carcinoma: The evidence presented herein provides additional support for the proposed tumor suppressor role of (AChE), which makes it a potential therapeutic target in hepatocellular carcinoma as in some patients with liver cancers, hepatic samples showed a reduction in AChE activity in comparison with normal tissue34.